Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study.

ABSTRACT:

Background

Patient-reported outcomes (PRO) measures relevant to domains most important to patients with HCC who received locoregional therapies are needed to advance patient-centered research. Furthermore, electronic PRO monitoring in clinical care has been shown to reduce hospitalizations and deaths in patients with other cancers. We conducted a qualitative study among patients with HCC who recently received locoregional therapies to (1) identify common and distressing posttreatment symptoms to prioritize PRO domain selection and (2) gauge interest in an electronic PRO symptom monitoring system.

Methods

We performed semi-structured telephone interviews among adult patients who received locoregional therapies (median of 26 days after treatment) for treatment-naïve HCC at a s

SUBMITTER: Moon AM 

PROVIDER: S-EPMC10629737 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature